Polymerase Chain Reaction (PCR) Market (Product Type: Instruments, Reagents, and Consumables; and End-user: Pharmaceutical & Biotechnology Industries, Clinical Diagnostic Labs & Hospitals, Academic & Research Organizations, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
Polymerase Chain Reaction Market – Scope of Report
TMR’s report on the global polymerase chain reaction market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global polymerase chain reaction market for the period 2017–2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global polymerase chain reaction market from 2021 to 2028.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global polymerase chain reaction market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global polymerase chain reaction market.
The report includes an elaborate executive summary along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global polymerase chain reaction market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global polymerase chain reaction market.
The report delves into the competition landscape of the global polymerase chain reaction market. Key players operating in the global polymerase chain reaction market have been identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global polymerase chain reaction market profiled in this report.
Key Questions Answered in Global Polymerase Chain Reaction Market Report
What will be the revenue generated in the polymerase chain reactions market across all geographies during the forecast period?
What are key trends in the global polymerase chain reactions market?
What are major drivers, restraints, and opportunities in the market?
Which region is set to expand at a high CAGR during the forecast period?
Which segment of the global polymerase chain reactions will generate the maximum revenue globally by 2028?
Which segment will expand at the maximum CAGR during the forecast period?
Polymerase Chain Reaction Market – Research Objectives and Research Approach
The comprehensive report on the global polymerase chain reaction market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global polymerase chain reaction market in terms of product type, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2028 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global polymerase chain reaction market.
- 1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
- 2. Assumptions and Research Methodology
- 3. Executive Summary: Global PCR Market
- 4. Market Overview
- 4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.3.4. Trends
- 4.4. Global PCR Market Analysis and Forecast, 2017–2028
- 4.4.1. Market Revenue Projections (US$ Mn)
- 4.5. Porter’s Five Force Analysis
- 5. Market Outlook
- 5.1. Product Portfolio Analysis, by Key Players
- 5.2. Distributor Analysis, by Key Players
- 5.3. End-user Expectations from PCR Reagents & Instruments Manufacturers
- 5.4. Market Value Share Analysis (%): by PCR Technology
- 5.5. Clinical Diagnostic PCR Value Share (%) by Type of Diseases/Disorder
- 6. Global PCR Market Analysis and Forecast, by Product
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Product, 2017–2028
- 6.3.1. Instruments
- 6.3.1.1. Standard PCR Systems
- 6.3.1.2. RT PCR Systems
- 6.3.1.3. Digital PCR Systems
- 6.3.2. Reagents
- 6.3.3. Consumables
- 6.4. Market Attractiveness Analysis, by Product
- 7. Global PCR Market Analysis and Forecast, by End-user
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by End-user, 2017–2028
- 7.3.1. Pharmaceutical & Biotechnology Industries
- 7.3.2. Clinical Diagnostics Labs & Hospitals
- 7.3.3. Academic & Research Organizations
- 7.3.4. Others
- 7.4. Market Attractiveness Analysis, by End-user
- 8. Global PCR Market Analysis and Forecast, by Region
- 8.1. Key Findings
- 8.2. Market Value Forecast, by Region
- 8.2.1. North America
- 8.2.2. Europe
- 8.2.3. Asia Pacific
- 8.2.4. Rest of the World
- 8.3. Market Attractiveness Analysis, by Country/Region
- 9. North America PCR Market Analysis and Forecast
- 9.1. Introduction
- 9.1.1. Key Findings
- 9.2. Market Value Forecast, by Product, 2017–2028
- 9.2.1. Instruments
- 9.2.1.1. Standard PCR Systems
- 9.2.1.2. RT PCR Systems
- 9.2.1.3. Digital PCR Systems
- 9.2.2. Reagents
- 9.2.3. Consumables
- 9.3. Market Value Forecast, by End-user, 2017–2028
- 9.3.1. Pharmaceutical & Biotechnology Industries
- 9.3.2. Clinical Diagnostics Labs & Hospitals
- 9.3.3. Academic & Research Organizations
- 9.3.4. Others
- 9.4. Market Value Forecast, by Country, 2017–2028
- 9.4.1. U.S.
- 9.4.2. Canada
- 9.5. Market Attractiveness Analysis
- 9.5.1. by Product
- 9.5.2. by End-user
- 9.5.3. by Country
- 10. Europe PCR Market Analysis and Forecast
- 10.1. Introduction
- 10.1.1. Key Findings
- 10.2. Market Value Forecast, by Product, 2017–2028
- 10.2.1. Instruments
- 10.2.1.1. Standard PCR Systems
- 10.2.1.2. RT PCR Systems
- 10.2.1.3. Digital PCR Systems
- 10.2.2. Reagents
- 10.2.3. Consumables
- 10.3. Market Value Forecast, by End-user, 2017–2028
- 10.3.1. Pharmaceutical & Biotechnology Industries
- 10.3.2. Clinical Diagnostics Labs & Hospitals
- 10.3.3. Academic & Research Organizations
- 10.3.4. Others
- 10.4. Market Value Forecast, by Country/Sub-region, 2017–2028
- 10.4.1. Germany
- 10.4.2. U.K.
- 10.4.3. France
- 10.4.4. Spain
- 10.4.5. Italy
- 10.4.6. Rest of Europe
- 10.5. Market Attractiveness Analysis
- 10.5.1. by Product
- 10.5.2. by End-user
- 10.5.3. by Country/Sub-region
- 11. Asia Pacific PCR Market Analysis and Forecast
- 11.1. Introduction
- 11.1.1. Key Findings
- 11.2. Market Value Forecast, by Product, 2017–2028
- 11.2.1. Instruments
- 11.2.1.1. Standard PCR Systems
- 11.2.1.2. RT PCR Systems
- 11.2.1.3. Digital PCR Systems
- 11.2.2. Reagents
- 11.2.3. Consumables
- 11.3. Market Value Forecast, by End-user, 2017–2028
- 11.3.1. Pharmaceutical & Biotechnology Industries
- 11.3.2. Clinical Diagnostics Labs & Hospitals
- 11.3.3. Academic & Research Organizations
- 11.3.4. Others
- 11.4. Market Value Forecast, by Country/Sub-region, 2017–2028
- 11.4.1. China
- 11.4.2. Japan
- 11.4.3. India
- 11.4.4. Australia & New Zealand
- 11.4.5. Rest of Asia Pacific
- 11.5. Market Attractiveness Analysis
- 11.5.1. by Product
- 11.5.2. by End-user
- 11.5.3. by Country/Sub-region
- 12. Rest of the World PCR Market Analysis and Forecast
- 12.1. Introduction
- 12.1.1. Key Findings
- 12.2. Market Value Forecast, by Product, 2017–2028
- 12.2.1. Instruments
- 12.2.1.1. Standard PCR Systems
- 12.2.1.2. RT PCR Systems
- 12.2.1.3. Digital PCR Systems
- 12.2.2. Reagents
- 12.2.3. Consumables
- 12.3. Market Value Forecast, by End-user, 2017–2028
- 12.3.1. Pharmaceutical & Biotechnology Industries
- 12.3.2. Clinical Diagnostics Labs & Hospitals
- 12.3.3. Academic & Research Organizations
- 12.3.4. Others
- 12.4. Market Attractiveness Analysis
- 12.4.1. by Product
- 12.4.2. by End-user
- 13. Competition Landscape
- 13.1. Market Player - Competition Matrix Competition Matrix (by tier and size of companies)
- 13.2. Market Share Analysis by Company (2020)
- 13.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
- 13.3.1. Bio-Rad Laboratories, Inc.
- 13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.1.2. Product Portfolio
- 13.3.1.3. SWOT Analysis
- 13.3.1.4. Financial Overview
- 13.3.1.5. Strategic Overview
- 13.3.2. QIAGEN N.V.
- 13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.2.2. Product Portfolio
- 13.3.2.3. SWOT Analysis
- 13.3.2.4. Financial Overview
- 13.3.2.5. Strategic Overview
- 13.3.3. F. Hoffmann-La Roche AG
- 13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.3.2. Product Portfolio
- 13.3.3.3. SWOT Analysis
- 13.3.3.4. Financial Overview
- 13.3.3.5. Strategic Overview
- 13.3.4. Thermo Fisher Scientific, Inc.
- 13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.4.2. Product Portfolio
- 13.3.4.3. SWOT Analysis
- 13.3.4.4. Financial Overview
- 13.3.4.5. Strategic Overview
- 13.3.5. Becton, Dickinson and Company
- 13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.5.2. Product Portfolio
- 13.3.5.3. SWOT Analysis
- 13.3.5.4. Financial Overview
- 13.3.5.5. Strategic Overview
- 13.3.6. Abbott
- 13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.6.2. Product Portfolio
- 13.3.6.3. SWOT Analysis
- 13.3.6.4. Financial Overview
- 13.3.6.5. Strategic Overview
- 13.3.7. Siemens Healthcare GmbH (Siemens AG)
- 13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.7.2. Product Portfolio
- 13.3.7.3. SWOT Analysis
- 13.3.7.4. Financial Overview
- 13.3.7.5. Strategic Overview
- 13.3.8. BioMérieux SA
- 13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.8.2. Product Portfolio
- 13.3.8.3. SWOT Analysis
- 13.3.8.4. Financial Overview
- 13.3.8.5. Strategic Overview
- 13.3.9. Danaher Corporation
- 13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.9.2. Product Portfolio
- 13.3.9.3. SWOT Analysis
- 13.3.9.4. Financial Overview
- 13.3.9.5. Strategic Overview
- 13.3.10. Agilent Technologies
- 13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.10.2. Product Portfolio
- 13.3.10.3. SWOT Analysis
- 13.3.10.4. Financial Overview
- 13.3.10.5. Strategic Overview
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook